{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:40:38Z","timestamp":1774572038028,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Braz J Microbiol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s42770-025-01762-2","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T08:46:30Z","timestamp":1755247590000},"page":"2671-2686","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pharmacological evaluation of phage-antibiotic synergism against clinical isolates of multi-drug resistant Staphylococcus aureus in a burn-induced infection mouse model"],"prefix":"10.1007","volume":"56","author":[{"given":"Syed Damin Abbas","family":"Hamdani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9005-8991","authenticated-orcid":false,"given":"Mustafeez Mujtaba","family":"Babar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huma","family":"Sajjad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alvina","family":"Gul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mudassira","family":"Zahid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tausif Ahmed","family":"Rajput","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aneeqa","family":"Noor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madiha","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Dennehy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,15]]},"reference":[{"key":"1762_CR1","unstructured":"O\u2019Neill J (2014) Antimicrobial resistance: tackling a crisis for the health and wealth of nations\/the review on antimicrobial resistance chaired by Jim. O\u2019Neill. Wellcome Collection"},{"issue":"1","key":"1762_CR2","doi-asserted-by":"publisher","first-page":"12689","DOI":"10.1038\/s41598-020-69058-z","volume":"10","author":"A Shariati","year":"2020","unstructured":"Shariati A, Dadashi M, Moghadam MT, van Belkum A, Yaslianifard S, Darban-Sarokhalil D (2020) Global prevalence and distribution of Vancomycin resistant, Vancomycin intermediate and heterogeneously Vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis. Sci Rep 10(1):12689","journal-title":"Sci Rep"},{"issue":"657","key":"1762_CR3","doi-asserted-by":"publisher","first-page":"eabo7793","DOI":"10.1126\/scitranslmed.abo7793","volume":"14","author":"MA Cook","year":"2022","unstructured":"Cook MA, Wright GD (2022) The past, present, and future of antibiotics. Sci Transl Med 14(657):eabo7793","journal-title":"Sci Transl Med"},{"key":"1762_CR4","doi-asserted-by":"crossref","unstructured":"Iskandar K, Murugaiyan J, Hammoudi Halat D, Hage SE, Chibabhai V, Adukkadukkam S, Roques C, Molinier L, Salameh P, Van Dongen M (2022) Antibiotic discovery and resistance: the chase and the race. Antibiotics 11(2):182","DOI":"10.3390\/antibiotics11020182"},{"key":"1762_CR5","doi-asserted-by":"publisher","first-page":"1199657","DOI":"10.3389\/fmed.2023.1199657","volume":"10","author":"L Blasco","year":"2023","unstructured":"Blasco L, L\u00f3pez-Hern\u00e1ndez I, Rodr\u00edguez-Fern\u00e1ndez M, P\u00e9rez-Florido J, Casimiro-Soriguer CS, Djebara S, Merabishvili M, Pirnay J-P, Rodr\u00edguez-Ba\u00f1o J, Tom\u00e1s M (2023) Case report: analysis of phage therapy failure in a patient with a Pseudomonas aeruginosa prosthetic vascular graft infection. Front Med 10:1199657","journal-title":"Front Med"},{"key":"1762_CR6","doi-asserted-by":"publisher","first-page":"692614","DOI":"10.3389\/fphar.2021.692614","volume":"12","author":"AV Johri","year":"2021","unstructured":"Johri AV, Johri P, Hoyle N, Pipia L, Nadareishvili L, Nizharadze D (2021) Case report: chronic bacterial prostatitis treated with phage therapy after multiple failed antibiotic treatments. Front Pharmacol 12:692614","journal-title":"Front Pharmacol"},{"issue":"3","key":"1762_CR7","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S1473-3099(20)30330-3","volume":"21","author":"L Leitner","year":"2021","unstructured":"Leitner L, Ujmajuridze A, Chanishvili N, Goderdzishvili M, Chkonia I, Rigvava S, Chkhotua A, Changashvili G, McCallin S, Schneider MP (2021) Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trial. Lancet Infect Dis 21(3):427\u2013436","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"1762_CR8","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1001\/jamaoto.2019.1191","volume":"145","author":"ML Ooi","year":"2019","unstructured":"Ooi ML, Drilling AJ, Morales S, Fong S, Moraitis S, Macias-Valle L, Vreugde S, Psaltis AJ, Wormald P-J (2019) Safety and tolerability of bacteriophage therapy for chronic rhinosinusitis due to Staphylococcus aureus. JAMA Otolaryngology\u2013Head Neck Surg 145(8):723\u2013729","journal-title":"JAMA Otolaryngology\u2013Head Neck Surg"},{"issue":"1","key":"1762_CR9","doi-asserted-by":"publisher","first-page":"5526","DOI":"10.1038\/s41467-019-13445-2","volume":"10","author":"BN Watson","year":"2019","unstructured":"Watson BN, Vercoe RB, Salmond GP, Westra ER, Staals RHJ, Fineran PC (2019) Type IF CRISPR-Cas resistance against virulent phages results in abortive infection and provides population-level immunity. Nat Commun 10(1):5526","journal-title":"Nat Commun"},{"issue":"11","key":"1762_CR10","first-page":"1800","volume":"16","author":"J Young","year":"2024","unstructured":"Young J, Shariyate MJ, Misra P, Laiwala S, Nazarian A, Rodriguez EK (2024) Assessment of bacteriophage Pharmacokinetic parameters after Intra-Articular delivery in a rat. Prosthet Joint Infect Model Viruses 16(11):1800","journal-title":"Prosthet Joint Infect Model Viruses"},{"key":"1762_CR11","doi-asserted-by":"publisher","unstructured":"Gu Liu C, Green SI, Min L, Clark JR, Salazar KC, Terwilliger AL, Kaplan HB, Trautner BW, Ramig RF, Maresso AW (2020) Phage-antibiotic synergy is driven by a unique combination of antibacterial mechanism of action and stoichiometry. MBio. 11(4). https:\/\/doi.org\/10.1128\/mbio. 01462\u2009\u2013\u200901420","DOI":"10.1128\/mbio"},{"key":"1762_CR12","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ejpb.2020.11.019","volume":"158","author":"Y Lin","year":"2021","unstructured":"Lin Y, Quan D, Chang RYK, Chow MY, Wang Y, Li M, Morales S, Britton WJ, Kutter E, Li J (2021) Synergistic activity of phage PEV20-ciprofloxacin combination powder formulation\u2014A proof-of-principle study in a P. aeruginosa lung infection model. Eur J Pharm Biopharm 158:166\u2013171","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"1762_CR13","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1128\/JB.01018-13","volume":"196","author":"AM Nanda","year":"2014","unstructured":"Nanda AM, Heyer A, Kr\u00e4mer C, Gr\u00fcnberger A, Kohlheyer D, Frunzke J (2014) Analysis of SOS-induced spontaneous prophage induction in Corynebacterium glutamicum at the single-cell level. J Bacteriol 196(1):180\u2013188","journal-title":"J Bacteriol"},{"issue":"22","key":"1762_CR14","first-page":"e02085","volume":"84","author":"M Kim","year":"2018","unstructured":"Kim M, Jo Y, Hwang YJ, Hong HW, Hong SS, Park K, Myung H (2018) Phage-antibiotic Synergy Via Delayed Lysis Appl Environ Microbiol 84(22):e02085\u2013e02018","journal-title":"Phage-antibiotic Synergy Via Delayed Lysis Appl Environ Microbiol"},{"issue":"4","key":"1762_CR15","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3390\/antibiotics8040182","volume":"8","author":"ST Abedon","year":"2019","unstructured":"Abedon ST (2019) Phage-antibiotic combination treatments: antagonistic impacts of antibiotics on the pharmacodynamics of phage. therapy? Antibiot 8(4):182","journal-title":"therapy? Antibiot"},{"issue":"6","key":"1762_CR16","doi-asserted-by":"publisher","first-page":"106200","DOI":"10.1016\/j.ijantimicag.2020.106200","volume":"56","author":"L Wang","year":"2020","unstructured":"Wang L, Tkhilaishvili T, Bernal Andres B, Trampuz A, Gonzalez Moreno M (2020) Bacteriophage\u2013antibiotic combinations against ciprofloxacin\/ceftriaxone-resistant Escherichia coli in vitro and in an experimental galleria Mellonella model. Int J Antimicrob Agents 56(6):106200","journal-title":"Int J Antimicrob Agents"},{"issue":"10369","key":"1762_CR17","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1016\/S0140-6736(22)02185-7","volume":"400","author":"KS Ikuta","year":"2022","unstructured":"Ikuta KS, Swetschinski LR, Aguilar GR, Sharara F, Mestrovic T, Gray AP, Weaver ND, Wool EE, Han C, Hayoon AG (2022) Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the global burden of disease study 2019. Lancet 400(10369):2221\u20132248","journal-title":"Lancet"},{"issue":"5","key":"1762_CR18","doi-asserted-by":"publisher","first-page":"e1045","DOI":"10.1093\/cid\/ciaa1717","volume":"73","author":"V Vella","year":"2021","unstructured":"Vella V, Galgani I, Polito L, Arora AK, Creech CB, David MZ, Lowy FD, Macesic N, Ridgway JP, Uhlemann A-C (2021) Staphylococcus aureus skin and soft tissue infection recurrence rates in outpatients: a retrospective database study at 3 US medical centers. Clin Infect Dis 73(5):e1045\u2013e1053","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1762_CR19","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s10068-016-0153-0","volume":"25","author":"A Jo","year":"2016","unstructured":"Jo A, Ding T, Ahn J (2016) Synergistic antimicrobial activity of bacteriophages and antibiotics against Staphylococcus aureus. Food Sci Biotechnol 25(3):935\u2013940","journal-title":"Food Sci Biotechnol"},{"key":"1762_CR20","unstructured":"Foster T (1996) Staphylococcus. Medical Microbiology. 4th edition"},{"key":"1762_CR21","unstructured":"Lewis I, James S (2022) Performance standards for antimicrobial susceptibility testing. (No Title)"},{"issue":"5","key":"1762_CR22","first-page":"671","volume":"13","author":"Y Elahi","year":"2021","unstructured":"Elahi Y, Nowroozi J, Fard RMN (2021) Isolation and characterization of bacteriophages from wastewater sources on Enterococcus spp. Isolated from clinical samples. Iran J Microbiol 13(5):671\u2013677","journal-title":"Iran J Microbiol"},{"key":"1762_CR23","unstructured":"Clokie M, Kropinski A (2009) Methods and protocols: isolation, characterization, and interactions. Methods in molecular biology. Humana press 1;69\u201381"},{"issue":"4","key":"1762_CR24","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3390\/microorganisms8040542","volume":"8","author":"Q Peng","year":"2020","unstructured":"Peng Q, Fang M, Liu X, Zhang C, Liu Y, Yuan Y (2020) Isolation and characterization of a novel phage for controlling multidrug-resistant Klebsiella pneumoniae. Microorganisms 8(4):542","journal-title":"Microorganisms"},{"issue":"1","key":"1762_CR25","doi-asserted-by":"publisher","first-page":"10080","DOI":"10.1038\/srep10080","volume":"5","author":"B Nejman-Fale\u0144czyk","year":"2015","unstructured":"Nejman-Fale\u0144czyk B, Bloch S, Licznerska K, Dydecka A, Felczykowska A, Topka G, W\u0119grzyn A, W\u0119grzyn G (2015) A small, microRNA-size, ribonucleic acid regulating gene expression and development of Shiga toxin-converting bacteriophage \u03a624\u0392. Sci Rep 5(1):10080","journal-title":"Sci Rep"},{"key":"1762_CR26","doi-asserted-by":"crossref","unstructured":"Yamamoto KR, Alberts BM, Benzinger R, Lawhorne L, Treiber GJV (1970) Rapid bacteriophage sedimentation in the presence of polyethylene glycol and its application to large-scale virus purification. Virology 40(3):734\u2013744","DOI":"10.1016\/0042-6822(70)90218-7"},{"issue":"11","key":"1762_CR27","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.1128\/AEM.02317-08","volume":"75","author":"JM Labont\u00e9","year":"2009","unstructured":"Labont\u00e9 JM, Reid KE, Suttle CA (2009) Phylogenetic analysis indicates evolutionary diversity and environmental segregation of marine podovirus DNA polymerase gene sequences. Appl Environ Microbiol 75(11):3634\u20133640","journal-title":"Appl Environ Microbiol"},{"key":"1762_CR28","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.3389\/fmicb.2017.01618","volume":"8","author":"A Dydecka","year":"2017","unstructured":"Dydecka A, Bloch S, Rizvi A, Perez S, Nejman-Falenczyk B, Topka G, Gasior T, Necel A, Wegrzyn G, Donaldson LW (2017) Bad phages in good bacteria: role of the mysterious orf63 of \u03bb and Shiga toxin-converting \u03a624B bacteriophages. Front Microbiol 8:1618","journal-title":"Front Microbiol"},{"key":"1762_CR29","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.3389\/fmicb.2017.02193","volume":"8","author":"K Fong","year":"2017","unstructured":"Fong K, LaBossiere B, Switt AI, Delaquis P, Goodridge L, Levesque RC, Danyluk MD, Wang S (2017) Characterization of four novel bacteriophages isolated from British Columbia for control of non-typhoidal Salmonella in vitro and on sprouting alfalfa seeds. Front Microbiol 8:2193","journal-title":"Front Microbiol"},{"key":"1762_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.lfs.2017.09.034","volume":"190","author":"M Jamal","year":"2017","unstructured":"Jamal M, Andleeb S, Jalil F, Imran M, Nawaz MA, Hussain T, Ali M, Das CR (2017) Isolation and characterization of a bacteriophage and its utilization against multi-drug resistant Pseudomonas aeruginosa-2995. Life Sci 190:21\u201328","journal-title":"Life Sci"},{"issue":"8","key":"1762_CR31","first-page":"469","volume":"9","author":"L Elias","year":"2020","unstructured":"Elias L, Balasubramanyam AS, Ayshpur OY, Mushtuk IU, Sheremet NO, Gumeniuk VV, Musser JM, Rogovskyy AS (2020) Antimicrobial susceptibility of Staphylococcus aureus, Streptococcus agalactiae, and Escherichia coli isolated from mastitic. Dairy Cattle Ukraine Antibiot 9(8):469","journal-title":"Dairy Cattle Ukraine Antibiot"},{"issue":"1","key":"1762_CR32","doi-asserted-by":"publisher","first-page":"100415","DOI":"10.1016\/j.phyplu.2023.100415","volume":"3","author":"H Fatima","year":"2023","unstructured":"Fatima H, Hamdani SDA, Ahmed M, Rajput TA, Gul A, Amir R, Munir F, Malik SZ, Babar MM (2023) Anti-MRSA potential of biogenic silver nanoparticles synthesized from hydroponically grown foeniculum vulgare. Phytomedicine Plus 3(1):100415","journal-title":"Phytomedicine Plus"},{"key":"1762_CR33","doi-asserted-by":"publisher","unstructured":"Humphries RM, Ambler J, Mitchell SL, Castanheira M, Dingle T, Hindler JA, Koeth L (2018) and K. J. J. o. c. m. Sei CLSI methods development and standardization working group best practices for evaluation of antimicrobial susceptibility tests. 56(4):01934\u2009\u2013\u200901917. https:\/\/doi.org\/10.1128\/jcm","DOI":"10.1128\/jcm"},{"key":"1762_CR34","unstructured":"Samuel P, Kumar YS, Suthakar BJ, Karawita J, Kumar DS, Vedha V, Shah H, Thakkar K, SunilKumar D, Vedha V (2023) Methicillin-resistant Staphylococcus aureus colonization in intensive care and burn units: a narrative review. Cureus J Med Science 15(10)"},{"key":"1762_CR35","doi-asserted-by":"publisher","first-page":"1356179","DOI":"10.3389\/fphar.2024.1356179","volume":"15","author":"A Loganathan","year":"2024","unstructured":"Loganathan A, Bozdogan B, Manohar P, Nachimuthu R (2024) Phage-antibiotic combinations in various treatment modalities to manage MRSA infections. Front Pharmacol 15:1356179","journal-title":"Front Pharmacol"},{"issue":"3","key":"1762_CR36","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1128\/AEM.05741-11","volume":"78","author":"R Edgar","year":"2012","unstructured":"Edgar R, Friedman N, Molshanski-Mor S, Qimron U (2012) Reversing bacterial resistance to antibiotics by phage-mediated delivery of dominant sensitive genes. Appl Environ Microbiol 78(3):744\u2013751","journal-title":"Appl Environ Microbiol"},{"issue":"3","key":"1762_CR37","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1089\/mdr.2006.12.164","volume":"12","author":"S Hagens","year":"2006","unstructured":"Hagens S, Habel A, Bl\u00e4si U (2006) Augmentation of the antimicrobial efficacy of antibiotics by filamentous phage. Microb Drug Resist 12(3):164\u2013168","journal-title":"Microb Drug Resist"},{"issue":"5","key":"1762_CR38","doi-asserted-by":"publisher","first-page":"e3002119","DOI":"10.1371\/journal.pbio.3002119","volume":"21","author":"A Petrovic Fabijan","year":"2023","unstructured":"Petrovic Fabijan A, Iredell J, Danis-Wlodarczyk K, Kebriaei R, Abedon ST (2023) Translating phage therapy into the clinic: recent accomplishments but continuing challenges. PLoS Biol 21(5):e3002119","journal-title":"PLoS Biol"},{"issue":"1","key":"1762_CR39","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3390\/microorganisms9010152","volume":"9","author":"CM Davis","year":"2021","unstructured":"Davis CM, McCutcheon JG, Dennis JJ (2021) Aztreonam lysine increases the activity of phages E79 and PhiKZ against Pseudomonas aeruginosa PA01. Microorganisms 9(1):152","journal-title":"Microorganisms"},{"key":"1762_CR40","doi-asserted-by":"crossref","unstructured":"Liu C, Hong Q, Chang RYK, Kwok PCL, Chan H-K (2022) Phage\u2013antibiotic therapy as a promising strategy to combat multidrug-resistant infections and to enhance antimicrobial efficiency. Antibiotics 11(5):570","DOI":"10.3390\/antibiotics11050570"},{"key":"1762_CR41","doi-asserted-by":"crossref","unstructured":"Liu CG, Green SI, Min L, Clark JR, Salazar KC, Terwilliger AL, Kaplan HB, Trautner BW, Ramig RF, Maresso AW (2020) Phage-Antibiotic synergy is driven by a unique combination of antibacterial mechanism of action and stoichiometry. mBio. 11(4). https:\/\/doi.org\/10.1128\/mbio.01462\u201301420","DOI":"10.1128\/mBio.01462-20"},{"issue":"4","key":"1762_CR42","first-page":"667","volume":"36","author":"G Hosgood","year":"2006","unstructured":"Hosgood G (2006) Stages of wound healing and their clinical relevance. Veterinary Clinics: Small Anim Pract 36(4):667\u2013685","journal-title":"Veterinary Clinics: Small Anim Pract"},{"issue":"2","key":"1762_CR43","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3390\/v13020334","volume":"13","author":"BL Aghaee","year":"2021","unstructured":"Aghaee BL, Khan Mirzaei M, Alikhani MY, Mojtahedi A, Maurice CF (2021) Improving the inhibitory effect of phages against Pseudomonas aeruginosa isolated from a burn patient using a combination of phages and antibiotics. Viruses 13(2):334","journal-title":"Viruses"},{"key":"1762_CR44","doi-asserted-by":"crossref","unstructured":"Simon K, Pier W, Kr\u00fcttgen A, Horz HP (2021) Synergy between Phage Sb-1 and Oxacillin against Methicillin-Resistant Staphylococcus aureus. Antibiotics (Basel) 10(7)","DOI":"10.3390\/antibiotics10070849"},{"key":"1762_CR45","doi-asserted-by":"crossref","unstructured":"Save J, Que YA, Entenza J, Resch G (2022) Subtherapeutic Doses of Vancomycin Synergize with Bacteriophages for Treatment of Experimental Methicillin-Resistant Staphylococcus aureus Infective Endocarditis. Viruses 14(8)","DOI":"10.3390\/v14081792"},{"issue":"1","key":"1762_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0463.2009.02563.x","volume":"118","author":"KF KONG","year":"2010","unstructured":"KONG KF, Schneper L, Mathee K (2010) Beta-lactam antibiotics: from antibiosis to resistance and bacteriology. Apmis 118(1):1\u201336","journal-title":"Apmis"},{"key":"1762_CR47","doi-asserted-by":"publisher","first-page":"561210","DOI":"10.3389\/fmicb.2020.01785","volume":"11","author":"Z Podlesek","year":"2020","unstructured":"Podlesek Z, \u017dgur Bertok D (2020) The DNA damage inducible SOS response is a key player in the generation of bacterial persister cells and population wide tolerance. Front Microbiol 11:561210","journal-title":"Front Microbiol"},{"key":"1762_CR48","doi-asserted-by":"publisher","first-page":"105906","DOI":"10.1016\/j.micpath.2022.105906","volume":"174","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Feng L, Zhou B, Zhang X, Yao Z, Wang L, Wang Z, Zhou T, Chen L (2023) A newly isolated bacteriophage vB8388 and its synergistic effect with aminoglycosides against multi-drug resistant Klebsiella Oxytoca strain FK-8388. Microb Pathog 174:105906","journal-title":"Microb Pathog"},{"issue":"3","key":"1762_CR49","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3390\/antibiotics8030103","volume":"8","author":"E Akturk","year":"2019","unstructured":"Akturk E, Oliveira H, Santos SB, Costa S, Kuyumcu S, Melo LDR, Azeredo J (2019) Synergistic action of phage and antibiotics: parameters to enhance the killing efficacy against mono and Dual-Species biofilms. Antibiotics 8(3):103","journal-title":"Antibiotics"}],"container-title":["Brazilian Journal of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-025-01762-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42770-025-01762-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-025-01762-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T11:14:20Z","timestamp":1764242060000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42770-025-01762-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,15]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1762"],"URL":"https:\/\/doi.org\/10.1007\/s42770-025-01762-2","relation":{},"ISSN":["1517-8382","1678-4405"],"issn-type":[{"value":"1517-8382","type":"print"},{"value":"1678-4405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,15]]},"assertion":[{"value":"22 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest related to the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}